Part 3.8 / M22, M23, M29

Index-Nr.

►M18  Chemische Bezeichnung ◄

EG-Nr.

CAS-Nr.

Einstufung

Kennzeichnung

►M18  Spezifische Konzentrationsgrenzen, M-Faktoren und ATE (*1)  ◄

Anmerkungen

►M16   ►C14  Kodierung der Gefahrenklassen und -kategorien ◄  ◄

Kodierung der Gefahrenhinweise

Piktogramm, Kodierung der Signalworte

Kodierung der Gefahrenhinweise

Kodierung der ergänzenden Gefahrenmerkmale

▼M16

006-069-00-3

Thiophanat-methyl (ISO);

Dimethyl-(1,2-phenylendicarbamothioyl)biscarbamat;

Dimethyl-4,4’-(o-phenylen)bis(3-thioallophanat)

245-740-7

23564-05-8

Carc. 2

Muta. 2

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H341

H332

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H341

H332

H317

H410

Einatmen: ATE = 1,7 mg/L

(Stäube und Nebel)

M = 10

M = 10

006-076-00-1

Mancozeb (ISO); Manganethylen-bis(dithiocarbamat) (polymer), Komplex mit Zinksalz

—

8018-01-7

Carc. 2

Repr. 1B

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360D

H373 (Schilddrüse, Nervensystem)

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H373 (Schilddrüse, Nervensystem)

H317

H410

M = 10

M = 10

007-004-00-1

Salpetersäure … % [C > 70 %]

231-714-2

7697-37-2

Ox. Liq. 2

Acute Tox. 1

Skin Corr. 1A

H272

H330

H314

GHS03

GHS06

GHS05

Dgr

H272

H330

H314

EUH071

Ox. Liq. 2; H272: C ≥ 99 %

Ox. Liq. 3; H272: 70 % ≤ C < 99 %

B

007-030-00-3

Salpetersäure … % [C ≤ 70 %]

231-714-2

7697-37-2

Ox. Liq. 3

Acute Tox. 3

Skin Corr. 1A

H272

H331

H314

GHS03

GHS06

GHS05

Dgr

H272

H331

H314

EUH071

Ox. Liq. 3; H272: C ≥ 65 %

Einatmen: ATE = 2,65 mg/L (Dämpfe)

Skin Corr. 1A; H314: C ≥ 20 %

Skin Corr. 1B; H314: 5 % ≤ C < 20 %

B

014-018-00-1

Octamethylcyclotetrasiloxan;

[D4]

209-136-7

556-67-2

Repr. 2

Aquatic Chronic 1

H361f ***

H410

GHS08

GHS09

Wng

H361f ***

H410

M = 10

014-048-00-5

Siliciumcarbidfasern (mit Durchmesser < 3 μm, Länge > 5 μm und Seitenverhältnis ≥ 3:1)

206-991-8

409-21-2

308076-74-6

Carc. 1B

H350i

GHS08

Dgr

H350i

014-049-00-0

Trimethoxyvinylsilan; Trimethoxy(vinyl)silan

220-449-8

2768-02-7

Skin Sens. 1B

H317

GHS07

Wng

H317

014-050-00-6

Tris(2-methoxyethoxy)vinylsilan;

6-(2-Methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecan

213-934-0

1067-53-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

015-113-00-0

Tolclofos-methyl (ISO);

O-(2,6-Dichlor-p-tolyl) O,O-dimethylthiophosphat

260-515-3

57018-04-9

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 1

M = 1

015-134-00-5

Pirimiphos-methyl (ISO);

O-[2-(Diethylamino)-6-methylpyrimidin-4-yl]O, O-dimethyl phosphorthioat

249-528-5

29232-93-7

Acute Tox. 4

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H372 (Nervensystem)

H400

H410

GHS07

GHS08

GHS09

Dgr

H302

H372 (Nervensystem)

H410

oral: ATE = 1414 mg/kg KG

M = 1000

M = 1000

015-181-00-1

Phosphin

232-260-8

7803-51-2

Flam. Gas 1

Press. Gas

Acute Tox. 1

Skin Corr. 1B

Aquatic Acute 1

H220

H330

H314

H400

GHS02

GHS04

GHS06

GHS05

GHS09

Dgr

H220

H330

H314

H400

Einatmen:

ATE = 10 ppmV (Gase)

U

015-189-00-5

Phenylbis(2,4,6-trimethylbenzoyl)phosphinoxid

423-340-5

162881-26-7

Skin Sens. 1A

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

016-098-00-3

Dimethyldisulfid

210-871-0

624-92-0

Flam. Liq. 2

Acute Tox. 3

Acute Tox. 3

STOT SE 3

STOT SE 1

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H225

H331

H301

H336

H370 (obere Atemwege, Einatmen)

H319

H317

H400

H410

GHS02

GHS06

GHS08

GHS09

Dgr

H225

H331

H301

H336

H370 (obere Atemwege, Einatmen)

H319

H317

H410

Einatmen: ATE = 5 mg/L (Dämpfe)

oral: ATE = 190 mg/kg KG

M = 1

M = 10

►C12  022-006-00-2 ◄

Titandioxid;

[in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm]

236-675-5

13463-67-7

Carc. 2

H351 (Einatmen)

GHS08

Wng

H351 (Einatmen)

V, W, 10

027-001-00-9

Cobalt

231-158-0

7440-48-4

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4

H350

H341

H360F

H334

H317

H413

GHS08

Dgr

H350

H341

H360F

H334

H317

H413

028-007-00-4

Trinickeldisulfid;

Nickelsubsulfid; [1]

Heazlewoodit [2]

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. 1A

Muta. 2

Acute Tox. 3

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H331

H372**

H317

H400

H410

GHS08

GHS06

GHS09

Dgr

H350i

H341

H331

H372**

H317

H410

Einatmen:

ATE = 0,92 mg/L

(Stäube oder Nebel)

028-018-00-4

Nickel-bis(sulfamidat);

Nickelsulfamat

237-396-1

13770-89-3

Carc. 1A

Muta. 2

Repr. 1B

Acute Tox. 4

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H302

H372**

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D***

H302

H372**

H334

H317

H410

Oral: ATE = 853 mg/kg KG (Anhydrat)

Oral: ATE = 1098 mg/kg KG (Tetrahydrat)

STOT RE 1;

H372: C ≥ 1 %

STOT RE 2;

H373: 0,1 % ≤ C < 1 %

Skin Sens. 1;

H317: C ≥ 0,01 %

M = 1

029-002-00-X

Dikupferoxid;

Kupfer(I)-oxid

215-270-7

1317-39-1

Acute Tox. 4

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H332

H302

H318

H410

Einatmen: ATE = 3,34 mg/L (Stäube oder Nebel)

oral: ATE = 500 mg/kg KG

M = 100

M = 10

029-015-00-0

Kupferthiocyanat

214-183-1

1111-67-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

EUH032

M = 10

M = 10

029-016-00-6

Kupfer(II)-oxid

215-269-1

1317-38-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

M = 10

029-017-00-1

Dikupferchloridtrihydroxid

215-572-9

1332-65-6

Acute Tox. 4

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H332

H301

H400

H410

GHS06

GHS09

Dgr

H332

H301

H410

Einatmen: ATE = 2,83 mg/L (Stäube oder Nebel)

oral: ATE = 299 mg/kg KG

M = 10

M = 10

029-018-00-7

Tetrakupferhexahydroxidsulfat; [1]

Tetrakupferhexahydroxidsulfathydrat [2]

215-582-3 [1]

215-582-3 [2]

1333-22-8 [1]

12527-76-3 [2]

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

oral: ATE = 500 mg/kg KG

M = 10

M = 10

029-019-01-X

Kupferflocken (mit einem Überzug aus aliphatischer Säure)

—

—

Acute Tox. 3

Acute Tox. 4

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H319

H400

H410

GHS06

GHS09

Dgr

H331

H302

H319

H410

Einatmen: ATE = 0,733 mg/L (Stäube oder Nebel)

oral: ATE = 500 mg/kg KG

M = 10

M = 10

029-020-00-8

Kupfer(II)-carbonat — Kupfer(II)-hydroxid (1:1)

235-113-6

12069-69-1

Acute Tox. 4

Acute Tox. 4

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H319

H400

H410

GHS07

GHS09

Wng

H332

H302

H319

H410

Einatmen: ATE = 1,2 mg/L (Stäube oder Nebel)

oral: ATE = 500 mg/kg KG

M = 10

M = 10

029-021-00-3

Kupferdihydroxid;

Kupfer(II)-hydroxid

243-815-9

20427-59-2

Acute Tox. 2

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H318

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H302

H318

H410

Einatmen: ATE = 0,47 mg/L (Stäube oder Nebel)

oral: ATE = 500 mg/kg KG

M = 10

M = 10

029-022-00-9

Bordeauxbrühe;

Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid

—

8011-63-0

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H332

H318

H410

Einatmen: ATE = 1,97 mg/L (Stäube oder Nebel)

M = 10

M = 1

029-023-00-4

Kupfersulfat-Pentahydrat

231-847-6

7758-99-8

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H302

H318

H410

oral: ATE = 481 mg/kg KG

M = 10

M = 1

029-024-00-X

Kupfer, granuliert

[Partikellänge: von 0,9 mm bis 6,0 mm; Partikelbreite: von 0,494 mm bis 0,949 mm]

231-159-6

7440-50-8

Aquatic Chronic 2

H411

GHS09

H411

029-025-00-5

Bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O’)kupfer;

Bis(N-cyclohexyl-diazenium-dioxy)-kupfer;

[Cu-HDO]

239-703-4

312600-89-8

15627-09-5

Flam. Sol. 1

Acute Tox. 4

STOT RE 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H228

H302

H373 (Leber)

H318

H400

H410

GHS02

GHS07

GHS08

GHS05

GHS09

Dgr

H228

H302

H373 (Leber)

H318

H410

oral: ATE = 360 mg/kg KG

M = 1

M = 1

050-021-00-4

Dichlordioctylstannan

222-583-2

3542-36-7

Repr. 1B

Acute Tox. 2

STOT RE 1

Aquatic Chronic 3

H360D

H330

H372 **

H412

GHS08

GHS06

Dgr

H360D

H330

H372 **

H412

Repr. 1B; H360 D: C ≥ 0,03 %

Einatmen: ATE = 0,098 mg/L (Stäube oder Nebel)

050-027-00-7

2-Ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat; [DOTE]

239-622-4

15571-58-1

Repr. 1B

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H372 (Immunsystem)

H400

H410

GHS08

GHS09

Dgr

H360D

H372 (Immunsystem)

H410

050-031-00-9

Dioctylzinndilaurat [1];

Dioctyl-, Bis(coco-acyloxy)-stannanderivate [2]

222-883-3 [1] 293-901-5 [2]

3648-18-8 [1] 91648-39-4 [2]

Repr. 1B

STOT RE 1

H360D

H372 (Immunsystem)

GHS08

Dgr

H360D

H372 (Immunsystem)

080-012-00-0

Methylquecksilberchlorid

204-064-2

115-09-3

Carc. 2

Repr. 1A

Lact.

Acute Tox. 2

Acute Tox. 2

Acute Tox. 2

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360Df

H362

H330

H310

H300

H372 (Nervensystem, Nieren)

H400

H410

GHS08

GHS06

GHS09

Dgr

H351

H360Df

H362

H330

H310

H300

H372 (Nervensystem, Nieren)

H410

Einatmen: ATE = 0,05 mg/L (Stäube oder Nebel)

Dermal: ATE = 50 mg/kg KG

Oral: ATE = 5 mg/kg KG

1

601-029-00-7

Dipenten;

Limonen [1]

(S)-p-Mentha-1,8-dien; l-Limonen [2]

trans-1-Methyl-4-(1-methylvinyl)cyclohexen; [3]

(±)-1-Methyl-4-(1-methylvinyl)-cyclohexen [4]

205-341-0 [1]

227-815-6 [2]

229-977-3 [3]

231-732-0 [4]

138-86-3 [1]

5989-54-8 [2]

6876-12-6 [3]

7705-14-8 [4]

Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H315

H317

H400

H410

GHS02

GHS07

GHS09

Wng

H226

H315

H317

H410

C

601-090-00-X

Benzo[rst]pentaphen

205-877-5

189-55-9

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

601-091-00-5

Dibenzo[b,def]chrysen;

Dibenzo[a,h]pyren

205-878-0

189-64-0

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

601-092-00-0

Dibenzo[def,p]chrysen;

Dibenzo[a,l]pyren

205-886-4

191-30-0

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

Carc. 1B; H350: C ≥ 0,001 %

601-093-00-6

1,4-Dimethylnaphthalin

209-335-9

571-58-4

Acute Tox. 4

Asp. Tox. 1

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 3

H302

H304

H319

H400

H412

GHS07

GHS08

GHS09

Dgr

H302

H304

H319

H410

oral: ATE = 1 300  mg/kg KG

M = 1

601-094-00-1

1-Isopropyl-4-methylbenzol;

p-Cymol

202-796-7

99-87-6

Flam. Liq. 3

Acute Tox. 3

Asp. Tox. 1

Aquatic Chronic 2

H226

H331

H304

H411

GHS02

GHS06

GHS08

GHS09

Dgr

H226

H331

H304

H411

Einatmen: ATE = 3 mg/L (Dämpfe)

601-095-00-7

p-Mentha-1,3-dien; 1-Isopropyl-4-methyl-1,3-cyclohexadien;

α-Terpinen

202-795-1

99-86-5

Flam. Liq. 3

Acute Tox. 4

Skin Sens. 1

Asp. Tox. 1

Aquatic Chronic 2

H226

H302

H317

H304

H411

GHS02

GHS07

GHS08

GHS09

Dgr

H226

H302

H317

H304

H411

oral: ATE = 1 680  mg/kg KG

601-096-00-2

(R)-p-Mentha-1,8-dien;

d-Limonen

227-813-5

5989-27-5

Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1B

Asp. Tox. 1

Aquatic Acute 1

Aquatic Chronic 3

H226

H315

H317

H304

H400

H412

GHS02

GHS07

GHS08

GHS09

Dgr

H226

H315

H317

H304

H410

M = 1

602-110-00-X

Tetrafluorethylen

204-126-9

116-14-3

Carc. 1B

H350

GHS08

Dgr

H350

603-023-00-X

Ethylenoxid;

Oxiran

200-849-9

75-21-8

Flam. Gas 1

Press. Gas

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 3

Acute Tox. 3

STOT SE 3

STOT SE 3

STOT RE 1

Skin Corr. 1

Eye Dam. 1

H220

H350

H340

H360Fd

H331

H301

H335

H336

H372 (Nervensystem)

H314

H318

GHS02

GHS08

GHS06

GHS05

Dgr

H220

H350

H340

H360Fd

H331

H301

H335

H336

H372 (Nervensystem)

H314

Einatmen: ATE = 700 ppm (Gase)

Oral: ATE = 100 mg/kg KG

U

603-024-00-5

1,4-Dioxan

204-661-8

123-91-1

Flam. Liq. 2

Carc. 1B

STOT SE 3

Eye Irrit. 2

H225

H350

H335

H319

GHS02

GHS08

GHS07

Dgr

H225

H350

H335

H319

EUH019

EUH066

D

603-065-00-9

m-Bis(2,3-epoxypropoxy)benzol;

Resorcinoldiglycidylether

202-987-5

101-90-6

Carc. 1B

Muta. 2

Acute Tox. 3

Acute Tox. 4

Skin Irrit. 2

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H350

H341

H311

H302

H315

H319

H317

H412

GHS08

GHS06

Dgr

H350

H341

H311

H302

H315

H319

H317

H412

dermal: ATE = 300 mg/kg KG oral: ATE = 500 mg/kg KG

603-066-00-4

7-Oxa-3-oxiranylbicyclo[4.1.0]heptan; 1,2-Epoxy-4-epoxyethylcyclohexan; 4-Vinylcyclohexendiepoxid

203-437-7

106-87-6

Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 3

Acute Tox. 4

H350

H341

H360F

H331

H302

GHS08

GHS06

Dgr

H350

H341

H360F

H331

H302

Einatmen: ATE = 0,5 mg/L (Stäube oder Nebel)

oral: ATE = 1 847  mg/kg KG

603-098-00-9

2-Phenoxyethanol

204-589-7

122-99-6

Acute Tox. 4

STOT SE 3

Eye Dam. 1

H302

H335

H318

GHS05

GHS07

Dgr

H302

H335

H318

oral:

ATE = 1 394  mg/kg KG

603-236-00-8

Ethanol, 2,2’-Iminobis-, N-(verzweigte und lineare C13-15-Akyl)-Derivate

308-208-6

97925-95-6

Repr. 1B

H360D

GHS08

Dgr

H360D

603-237-00-3

Ipconazol (ISO);

(1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorbenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

—

125225-28-7

115850-69-6

115937-89-8

Repr. 1B

Acute Tox. 4

STOT RE 2

Aquatic Chronic 1

H360D

H302

H373 (Augen, Haut, Leber)

H410

GHS08

GHS07

GHS09

Dgr

H360D

H302

H373 (Augen, Haut, Leber)

H410

oral: ATE = 500 mg/kg KG

M = 100

603-238-00-9

Bis(2-(2-methoxyethoxy)ethyl)ether; Tetraethylenglycoldimethylether

205-594-7

143-24-8

Repr. 1B

H360FD

GHS08

Dgr

H360FD

603-239-00-4

Paclobutrazol (ISO);

(2RS,3RS)-1-(4-Chlorphenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol

—

76738-62-0

Repr. 2

Acute Tox. 4

Acute Tox. 4

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H332

H302

H319

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H332

H302

H319

H410

Einatmen: ATE = 3,13 mg/L (Stäube oder Nebel)

oral: ATE = 490 mg/kg KG

M = 10

M = 10

603-240-00-X

2,2-Bis(brommethyl)propan-1,3-diol

221-967-7

3296-90-0

Carc. 1B

Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

603-241-00-5

Geraniol;

(2E)-3,7-Dimethylocta-2,6-dien-1-ol

203-377-1

106-24-1

Skin Sens. 1

H317

GHS07

Wng

H317

604-095-00-5

6,6’-Di-tert-butyl-2,2’-methylendi-p-kresol;

[DBMK]

204-327-1

119-47-1

Repr. 1B

H360F

GHS08

Dgr

H360F

605-005-00-7

Metaldehyd (ISO);

2,4,6,8-Tetramethyl-1,3,5,7-tetraoxacyclooctan

203-600-2

108-62-3

Flam. Sol. 2

Repr. 2

Acute Tox. 3

Aquatic Chronic 3

H228

H361f

H301

H412

GHS02

GHS08

GHS06

Dgr

H228

H361f

H301

H412

Oral: ATE = 283 mg/kg KG

605-041-00-3

2-(4-tert-Butylbenzyl)propionaldehyd

201-289-8

80-54-6

Repr. 1B

H360Fd

GHS08

Dgr

H360Fd

606-004-00-4

4-Methylpentan-2-on; Isobutylmethylketon

203-550-1

108-10-1

Flam. Liq. 2

Carc. 2

Acute Tox. 4

STOT SE 3

Eye Irrit. 2

H225

H351

H332

H336

H319

GHS02

GHS07

GHS08

Dgr

H225

H351

H332

H336

H319

EUH066

Einatmen: ATE = 11 mg/L (Dämpfe)

606-047-00-9

2-Benzyl-2-dimethylamino-4′-morpholinobutyrophenon

404-360-3

119313-12-1

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H41

606-152-00-X

(5-Chlor-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanon; Pyriofenon

—

688046-61-9

Carc. 2

Aquatic Chronic 1

H351

H410

GHS08

GHS09

Wng

H351

H410

M = 1

607-177-00-9

Tribenuron-methyl (ISO);

Methyl-2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoat

401-190-1

101200-48-0

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373

H317

H410

M = 100

M = 100

607-232-00-7

Pyridat (ISO);

O-(6-Chlor-3-phenylpyridazin-4-yl)-S-octylthiocarbonat

259-686-7

55512-33-9

Acute Tox. 4

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H302

H315

H317

H410

Oral: ATE = 500 mg/kg KG

M = 1

M = 10

607-247-00-9

Dodecylmethacrylat

205-570-6

142-90-5

STOT SE 3

H335

GHS07

Wng

H335

STOT SE 3; H335: C ≥ 10 %

607-256-00-8

Azoxystrobin (ISO);

Methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylat

—

131860-33-8

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H331

H400

H410

GHS06

GHS09

Dgr

H331

H410

Einatmen:

ATE = 0,7 mg/L (Stäube oder Nebel)

M = 10

M = 10

607-314-00-2

Ethofumesat (ISO);

(RS)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl-methansulfonat

247-525-3

26225-79-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

607-421-00-4

Cypermethrin (ISO);

α-Cyan-3-phenoxybenzyl 3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat; Cypermethrin cis/trans +/-40/60

257-842-9

52315-07-8

Acute Tox. 4

Acute Tox. 4

STOT SE 3

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H335

H373 (Nervensystem)

H400

H410

GHS07

GHS08

GHS09

Wng

H332

H302

H335

H373 (Nervensystem)

H410

oral: ATE = 500 mg/kg KG

Einatmen: ATE = 3,3 mg/L (Stäube oder Nebel)

M = 100000

M = 100000

607-424-00-0

Trifloxystrobin (ISO); Methyl(E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluor-m-tolyl)ethylidenaminooxy]-o-tolyl}acetat

—

141517-21-7

Lact.

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H362

H317

H400

H410

GHS07

GHS09

Wng

H362

H317

H410

M = 100

M = 10

607-434-00-5

Mecoprop-P (ISO) [1] und seine Salze;

(R)-2-(4-Chlor-2-methylphenoxy)propionsäure [1] und ihre Salze

240-539-0 [1]

16484-77-8 [1]

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H302

H318

H410

oral: ATE = 431 mg/kg KG

M = 10

M = 10

607-733-00-0

Cyflumetofen (ISO);

2-Methoxyethyl-(RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluor-o-tolyl)propionat

—

400882-07-7

Carc. 2

Skin Sens. 1A

H351

H317

GHS08

GHS07

Wng

H351

H317

607-737-00-2

Diisohexylphthalat

276-090-2

71850-09-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-738-00-8

MCPA-thioethyl (ISO);

S-ethyl (4-chlor-2-methylphenoxy)ethanthioat; S-ethyl 4-chlor-o-tolyloxythioacetat

246-831-4

25319-90-8

Acute Tox. 4

STOT RE. 2

Aquatic Acute 1 Aquatic Chronic 1

H302

H373 (Leber)

H400

H410

GHS07

GHS08

GHS09

Wng

H302

H373 (Leber)

H410

oral: ATE = 450 mg/kg KG

M = 10

M = 10

607-740-00-9

Diisooctylphthalat

248-523-5

27554-26-3

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-741-00-4

4-{[(6-chlorpyridin-3-yl)methyl](2,2-difluorethyl)amino}Furan-2(5H)-on; Flupyradifuron

—

951659-40-8

Acute Tox. 4

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 (Muskel)

H400

H410

GHS07

GHS08

GHS09

Wng

H302

H373 (Muskel)

H410

oral: ATE = 500 mg/kg KG

M = 10

M = 10

607-742-00-X

Thiencarbazon-methyl (ISO);

Methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonylsulfamoyl]-5- methylthiophen-3-carboxylat

—

317815-83-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1000

M = 1000

607-743-00-5

L-(+)-Milchsäure;

(2S)-2-Hydroxypropansäure

201-196-2

79-33-4

Skin Corr. 1C

Eye Dam. 1

H314

H318

GHS05

Dgr

H314

EUH071

607-744-00-0

2-Methoxyethylacrylat

221-499-3

3121-61-7

Flam. Liq. 3

Muta. 2

Repr. 1B

Acute Tox. 3

Acute Tox. 4

Skin Corr. 1C

Eye Dam. 1

Skin Sens. 1

H226

H341

H360FD

H331

H302

H314

H318

H317

GHS02

GHS05

GHS06

GHS08

Dgr

H226

H341

H360FD

H331

H302

H314

H317

EUH071

Einatmen: ATE = 2,7 mg/L (Dämpfe)

oral: ATE = 404 mg/kg KG

607-745-00-6

Glyoxylsäure … %

206-058-5

298-12-4

Eye Dam. 1

Skin Sens. 1B

H318

H317

GHS05

GHS07

Dgr

H318

H317

B

607-746-00-1

Natrium-N-(hydroxymethyl)glycinat;

[aus Natrium-N-(hydroxymethyl)glycinat freigesetztes Formaldehyd]

274-357-8

70161-44-3

Carc. 1B

Muta. 2

Acute Tox. 4

Acute Tox. 4

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

Skin Sens. 1

H350

H341

H332

H302

H335

H315

H319

H317

GHS08

GHS07

Dgr

H350

H341

H332

H302

H335

H315

H319

H317

Einatmen: ATE = 3 mg/L (Stäube oder Nebel)

oral: ATE = 1100 mg/kg KG

8

9

607-747-00-7

2,2-Dibrom-2-cyanacetamid [DBNPA]

233-539-7

10222-01-2

Acute Tox. 2

Acute Tox. 3

STOT RE 1

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H372 (Atemwege) (Einatmen)

H315

H318

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H330

H301

H372 (Atemwege) (Einatmen)

H315

H318

H317

H410

Einatmen: ATE = 0,24 mg/L (Stäube oder Nebel)

oral: ATE = 118 mg/kg KG

M = 1

M = 1

607-748-00-2

[S-(Z,E)]-5-(1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-diensäure;

S-Abscisinsäure

244-319-5

21293-29-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

607-749-00-8

Methylsalicylat

204-317-7

119-36-8

Repr. 2

Acute Tox. 4

Skin Sens. 1B

Aquatic Chronic 3

H361d

H302

H317

H412

GHS07

GHS08

Wng

H361d

H302

H317

H412

oral: ATE = 890 mg/kg KG

607-750-00-3

Citronensäure

201-069-1

77-92-9

Eye Irrit. 2

STOT SE 3

H319

H335

GHS07

Wng

H319

H335

607-751-00-9

Ethametsulfuron-methyl (ISO);

Methyl 2-({[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)benzoat

—

97780-06-8

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

M = 1 000

M = 100

607-752-00-4

Trinexapac-ethyl (ISO);

Ethyl-4-[cyclopropyl(hydroxy)methylen]-3,5-dioxocyclohexancarboxylat

—

95266-40-3

STOT RE 2

Skin Sens. 1B

Aquatic Chronic 1

H373 (Magen-Darm-Trakt)

H317

H410

GHS08

GHS07

GHS09

Wng

H373 (Magen-Darm-Trakt)

H317

H410

M = 1

607-753-00-X

(3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-[(2S,3R,4R,5R)-3,4-Dihydroxy-5,6-dimethylheptan-2-yl]-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-on; 24-Epibrassinolid;

—

78821-43-9

Aquatic Chronic 4

H413

H413

607-754-00-5

Benzylsalicylat

204-262-9

118-58-1

Skin Sens. 1B

H317

GHS07

Wng

H317

607-755-00-0

(RS)-1-{1-Ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethylmethylcarbonat;

Tolpyralat

—

1101132-67-5

Carc. 2

Repr. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361fd

H373 (Augen)

H400

H410

GHS08

GHS09

Wng

H351

H361fd

H373 (Augen)

H410

M = 10

M = 100

608-039-00-0

2-Phenylhexannitril

423-460-8

3508-98-3

Acute Tox. 4

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

Oral:

ATE = 500 mg/kg KG

608-058-00-4

Esfenvalerat (ISO);

(S)-α-Cyan-3-phenoxybenzyl-(S)-2-(4-chlorphenyl)-3-methylbutyrat

—

66230-04-4

Acute Tox. 3

Acute Tox. 3

STOT SE 1

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H370 (Nervensystem)

H373

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H370 (Nervensystem)

H373

H317

H410

oral; ATE = 88,5 mg/kg KG

Einatmen: ATE = 0,53 mg/L (Stäube oder Nebel)

M = 10 000

M = 10 000

608-069-00-4

Fludioxonil (ISO); 4-(2,2-Difluor-1,3-benzodioxol-4-yl)-1H-pyrrol-3-carbonitril

—

131341-86-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 10

609-041-00-4

2,4-Dinitrophenol

200-087-7

51-28-5

Acute Tox. 3 *

Acute Tox. 3

Acute Tox. 2

STOT RE 1

Aquatic Acute 1

H331

H311

H300

H372

H400

GHS06

GHS08

GHS09

Dgr

H331

H311

H300

H372

H400

dermal: ATE = 300 mg/kg KG oral: ATE = 30 mg/kg KG

609-064-00-X

Mesotrione (ISO);

2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexandion

—

104206-82-8

Repr. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H373 (Augen, Nervensystem)

H400

H410

GHS08

GHS09

Wng

H361d

H373 (Augen, Nervensystem)

H410

M = 10

M = 10

611-181-00-6

Kalium(oxido-NNO-azoxy)cyclohexan;

Cyclohexylhydroxydiazen-1-oxid, Kaliumsalz;

[K-HDO]

—

66603-10-9

Flam. Sol. 1

Acute Tox. 3

STOT RE 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H228

H301

H373 (Leber)

H315

H318

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H228

H301

H373 (Leber)

H315

H318

H411

oral: ATE = 136 mg/kg KG

612-067-00-9

3-Aminomethyl-3,5,5-trimethylcyclohexylamin

220-666-8

2855-13-2

Acute Tox. 4

Skin Corr. 1B

Eye Dam. 1

Skin Sens. 1A

H302

H314

H318

H317

GHS05

GHS07

Dgr

H302

H314

H317

oral: ATE = 1 030  mg/kg KG

Skin Sens. 1A; H317: C ≥ 0,001 %

612-252-00-4

Imidacloprid (ISO);

(E)-1-(6-Chlor-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamin;

(2E)-1-[(6-Chlorpyridin-3-yl) methyl]-N-nitroimidazolidin-2-imin

428-040-8

138261-41-3

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

oral: ATE = 131 mg/kg KG

M = 100

M = 1 000

612-294-00-3

Mecetroniumetilsulfat;

N-ethyl-N,N-dimethylhexadecan-1-aminiumethylsulfat;

Mecetroniumethylsulfat;

[MES]

221-106-5

3006-10-8

Skin Corr. 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H318

H400

H410

GHS05

GHS09

Dgr

H314

H410

EUH071

M = 100

M = 1000

613-048-00-8

Carbendazim (ISO); Methylbenzimidazol-2-ylcarbamat

234-232-0

10605-21-7

Muta. 1B

Repr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H340

H360FD

H317

H400

H410

GHS07

GHS08

GHS09

Dgr

H340

H360FD

H317

H410

M = 10

M = 10

613-054-00-0

Thiabendazol (ISO);

2-(Thiazol-4-yl)benzimidazol

205-725-8

148-79-8

Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

613-102-00-0

Dimethomorph (ISO); (E,Z)-4-(3-(4-Chlorphenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholin

404-200-2

110488-70-5

Repr. 1B

Aquatic Chronic 2

H360F

H411

GHS08

GHS09

Dgr

H360F

H411

613-111-00-X

1,2,4-Triazol

206-022-9

288-88-0

Repr. 1B

Acute Tox. 4

Eye Irrit. 2

H360FD

H302

H319

GHS08

GHS07

Dgr

H360FD

H302

H319

oral: ATE = 1 320  mg/kg KG

613-112-00-5

Octhilinon (ISO);

2-Octyl-2H-isothiazol-3-on; [OIT]

247-761-7

26530-20-1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 3

Skin Corr. 1

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1 Aquatic Chronic 1

H330

H311

H301

H314

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H311

H301

H314

H317

H410

EUH071

Einatmen: ATE = 0,27 mg/L (Stäube oder Nebel)

dermal: ATE = 311 mg/kg KG oral: ATE = 125 mg/kg KG

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 100

M = 100

613-115-00-1

Hymexazol (ISO);

3-Hydroxy-5-methylisoxazol

233-000-6

10004-44-1

Repr. 2

Acute Tox. 4

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H361d

H302

H318

H317

H411

GHS08

GHS07

GHS05

GHS09

Dgr

H361d

H302

H318

H317

H411

oral: ATE = 1600 mg/kg KG

613-125-00-6

Hexythiazox (ISO);

Trans-5-(4-chlorphenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidin-carboxamid

—

78587-05-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

613-166-00-X

Flumioxazin (ISO);

N-(7-Fluor-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-en-1,2-dicarboximid

—

103361-09-7

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GHS09

Wng

H361d

H410

M = 1 000

M = 1 000

613-202-00-4

Pymetrozin (ISO);

(E)-4,5-Dihydro-6-methyl-4-(3-pyridylmethylenamino)-1,2,4-triazin-3(2H)-on

—

123312-89-0

Carc. 2

Repr. 2

Aquatic Chronic 1

H351

H361fd

H410

GHS08

GHS09

Wng

H351

H361fd

H410

M = 1

613-208-00-7

Imazamox (ISO);

(RS)-2-(4-Isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinsäure

—

114311-32-9

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GHS09

Wng

H361d

H410

M = 10

M = 10

613-259-00-5

Imiprothrin (ISO);

Reaktionsmasse von: [2,4-Dioxo(prop-2-in-1-yl)imidazolidin-3-yl]methyl-(1R)-cis-chrysanthemat; [2,4-Dioxo(prop-2-in-1-yl)imidazolidin-3-yl]methyl-(1R)-trans-chrysanthemat;

428-790-6

72963-72-5

Carc. 2

Acute Tox. 4

Acute Tox. 4

STOT SE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H332

H302

H371 (Nervensystem; oral, Einatmen)

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H332

H302

H371 (Nervensystem; oral, Einatmen)

H410

Einatmen: ATE = 1,4 mg/L (Stäube oder Nebel)

oral: ATE = 550 mg/kg KG

M = 10

M = 10

613-267-00-9

Thiamethoxam (ISO);

3-(2-Chlor-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-yliden-N-nitroamin

428-650-4

153719-23-4

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H302

H400

H410

GHS07

GHS08

GHS09

Wng

H361fd

H302

H410

oral: ATE = 780 mg/kg KG

M = 10

M = 10

613-282-00-0

Triticonazol (ISO);

(RS)-(E)-5-(4-Chlorbenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

—

138182-18-0

Repr. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H361f

H373

H400

H410

GHS08

GHS09

Wng

H361f

H373

H410

M = 1

M = 1

613-329-00-5

Halosulfuron-methyl (ISO);

Methyl-3-chlor-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1-H-pyrazol-4-carboxylat

—

100784-20-1

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410

M = 1000

M = 1000

613-330-00-0

2-Methylimidazol

211-765-7

693-98-1

Repr. 1B

H360Df

GHS08

Dgr

H360Df

613-331-00-6

(2RS)-2-[4-(4-chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol;

Mefentrifluconazol

—

1417782-03-6

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 1

M = 1

613-332-00-1

Oxathiapiprolin (ISO);

1-(4-{4-[5-(2,6-difluorphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluormethyl)-1H-pyrazol-1-yl]ethanon

—

1003318-67-9

Aquatic Chronic 1

H410

GHS09

Wng

H410

M = 1

613-333-00-7

Zink-Pyrithion; (T-4)-bis[1-(hydroxy-.kappa.O)pyridin-2(1H)-thionato-.kappa.S]zink

236-671-3

13463-41-7

Repr. 1B

Acute Tox. 2

Acute Tox. 3

STOT RE 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H301

H372

H318

H400

H410

GHS08

GHS06

GHS05

GHS09

Dgr

H360D

H330

H301

H372

H318

H410

Einatmen: ATE = 0,14 mg/L (Stäube oder Nebel)

oral: ATE = 221 mg/kg KG

M = 1000

M = 10

613-334-00-2

Flurochloridon (ISO);

3-Chlor-4-(chlormethyl)-1-[3-(trifluormethyl)phenyl]pyrrolidin-2-on

262-661-3

61213-25-0

Repr. 1B

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360FD

H302

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H360FD

H302

H317

H410

oral: ATE = 500 mg/kg KG

M = 100

M = 100

613-335-00-8

4,5-Dichlor-2-octyl-2H-isothiazol-3-on; [DCOIT]

264-843-8

64359-81-5

Acute Tox. 2

Acute Tox. 4

Skin Corr. 1

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H314

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H302

H314

H317

H410

EUH071

Einatmen: ATE = 0,16 mg/L (Stäube oder Nebel)

oral: ATE = 567 mg/kg KG

Skin Irrit. 2; H315: 0,025 % ≤ C < 5 %

Eye Irrit. 2; H319: 0,025 % ≤ C < 3 %

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 100

M = 100

613-336-00-3

2-Methyl-1,2-benzothiazol-3(2H)-on;

[MBIT]

—

2527-66-4

Acute Tox. 4

Acute Tox. 3

Skin Corr. 1C

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 2

H312

H301

H314

H318

H317

H400

H411

GHS06

GHS05

GHS09

Dgr

H312

H301

H314

H317

H410

EUH071

dermal: ATE = 1100 mg/kg KG

oral: ATE = 175 mg/kg KG

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 1

613-337-00-9

Prothioconazol (ISO);

2-[2-(1-Chlorcyclopropyl)-3-(2-chlorphenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-thion

—

178928-70-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

M = 1

613-338-00-4

Azamethiphos (ISO); S-[(6-Chlor-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl]-O,O-dimethylthiophosphat

252-626-0

35575-96-3

Carc. 2

Acute Tox. 3

Acute Tox. 4

STOT SE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H331

H302

H370 (Nervensystem)

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H331

H302

H370 (Nervensystem)

H317

H410

Einatmen: ATE = 0,5 mg/L (Stäube oder Nebel)

oral: ATE = 500 mg/kg KG

M = 1 000

M = 1 000

613-339-00-X

3-Methylpyrazol

215-925-7

1453-58-3

Repr. 1B

Acute Tox. 4

STOT RE 2

Skin Corr. 1

Eye Dam. 1

H360D

H302

H373 (Lunge)

H314

H318

GHS08

GHS07

GHS05

Dgr

H360D

H302

H373 (Lunge)

H314

oral: ATE = 500 mg/kg KG

613-340-00-5

Clomazon (ISO); 2-(2-Chlorbenzyl)-4,4-dimethyl-1,2-oxazolidin-3-on

—

81777-89-1

Acute Tox. 4

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H400

H410

GHS07

GHS09

Wng

H332

H302

H410

Einatmen: ATE = 4,85 mg/L (Stäube oder Nebel)

oral: ATE = 768 mg/kg KG

M = 1

M = 1

614-030-00-2

Emamectinbenzoat (ISO); (4“R)-4-Deoxy-4“-(methylamino)avermectin B1 benzoat

—

155569-91-8

Acute Tox. 3

Acute Tox. 3

Acute Tox. 3

STOT SE 1

STOT RE 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H370 (Nervensystem)

H372 (Nervensystem)

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H331

H311

H301

H370 (Nervensystem)

H372 (Nervensystem)

H318

H410

Einatmen:

ATE = 0,663

mg/L (Stäube oder Nebel)

dermal:

ATE = 300

mg/kg KG

oral: ATE =

60 mg/kg KG

STOT RE 1; H372: C ≥ 5 %; STOT RE 2; H373: 0,5 % ≤ C < 5 %

M = 10 000

M = 10 000

616-014-00-0

Butanonoxim; Ethylmethylketoxim; Ethylmethylketonoxim

202-496-6

96-29-7

Carc. 1B

Acute Tox. 4

Acute Tox. 3

STOT SE 3

STOT SE 1

STOT RE 2

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H350

H312

H301

H336

H370 (obere Atemwege)

H373 (Blutkreislauf)

H315

H318

H317

GHS08

GHS06

GHS05

Dgr

H350

H312

H301

H336

H370 (obere Atemwege)

H373 (Blutkreislauf)

H315

H318

H317

dermal: ATE = 1100 mg/kg KG oral: ATE = 100 mg/kg KG

616-018-00-2

Diethyltoluamid (ISO): N, N-Diethyl-m-toluamid [deet]

205-149-7

134-62-3

Acute Tox. 4

Skin Irrit. 2

Eye Irrit. 2

H302

H315

H319

GHS07

Wng

H302

H315

H319

Oral:

ATE = 1892 mg/kg KG

616-032-00-9

Diflufenican (ISO);

N-(2,4-Difluorphenyl)-2-[3-(trifluormethyl)phenoxy]-3-pyridincarboxamid; 2′,4′-Difluor-2-(α,α,α-trifluor-m-tolyloxy)nicotinanilid

—

83164-33-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10 000

M = 1 000

616-106-00-0

Phenmedipham (ISO); Methyl-3-(3-methylcarbaniloyloxy)carbanilat

237-199-0

13684-63-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

M = 10

616-113-00-9

Desmedipham (ISO);

Ethyl-3-phenylcarbamoyloxyphenylcarbamat

237-198-5

13684-56-5

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GHS09

Wng

H361d

H410

M = 10

M = 10

616-225-00-8

(RS)-2-Methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid; Mandestrobin

—

173662-97-0

Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 10

616-226-00-3

Carboxin (ISO);

2-Methyl-N-phenyl-5,6-dihydro-1,4-oxathiin-3-carboxamid; 5,6-Dihydro-2-methyl-1,4-oxathiin-3-carboxanilid

226-031-1

5234-68-4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 (Nieren)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 (Nieren)

H317

H410

M = 1

M = 1

616-227-00-9

Metaflumizon (ISO); (EZ)-2’-[2-(4-Cyanophenyl)-1-(α,α,α-trifluor-m-tolyl)ethyliden]-[4-(trifluormethoxy)phenyl]carbanilohydrazid [E-Isomer ≥ 90 %, Z-Isomer ≤ 10 % relativer Anteil]; [1]

(E)-2’-[2-(4-Cyanophenyl)-1-(α,α,α-trifluor-m-tolyl)ethyliden]-[4-(trifluormethoxy)phenyl]carbanilohydrazid [2]

—

139968-49-3 [1]

852403-68-0 [2]

Repr. 2

Lact.

STOT RE 2

H361fd

H362

H373

GHS08

Wng

H361fd

H362

H373

616-228-00-4

3-(Difluormethyl)-1-methyl-N-(3‘,4’,5’-trifluorbiphenyl-2-yl)pyrazol-4-carboxamid;

Fluxapyroxad

—

907204-31-3

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

M = 1

M = 1

616-230-00-5

N-(hydroxymethyl)acrylamid; Methylolacrylamid; [NMA]

213-103-2

924-42-5

Carc. 1B

Muta. 1B

STOT RE 1

H350

H340

H372 (peripheres Nervensystem)

GHS08

Dgr

H350

H340

H372 (peripheres Nervensystem)

616-231-00-0

5-Fluor-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]-1H-pyrazol-4-carboxamid; 2’-[(RS)-1,3-dimethylbutyl]-5-fluor-1,3-dimethylpyrazol-4-carboxanilid;

Penflufen

—

494793-67-8

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 1

M = 1

616-232-00-6

Iprovalicarb (ISO);

Isopropyl [(2S)-3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamat

—

140923-17-7

Carc. 2

H351

GHS08

Wng

H351

616-233-00-1

Silthiofam (ISO);

N-Allyl-4,5-dimethyl-2-(trimethylsilyl)thiophen-3-carboxamid

—

175217-20-6

STOT RE 2

Aquatic Chronic 2

H373

H411

GHS08

GHS09

Wng

H373

H411

616-234-00-7

N-Methoxy-N-[1-methyl-2-(2,4,6-trichlorphenyl)-ethyl]-3-(difluormethyl)-1-methylpyrazol-4-carboxamid; Pydiflumetofen

—

1228284-64-7

Carc. 2

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361f

H400

H410

GHS08

GHS09

Wng

H351

H361f

H410

M = 1

M = 1

616-235-00-2

N-{2-[[1,1’-Bi(cyclopropyl)]-2-yl]phenyl}-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carboxamid; Sedaxan

—

874967-67-6

Carc. 2

Aquatic Acute 1

Aquatic Chronic 2

H351

H400

H411

GHS08

GHS09

Wng

H351

H410

M = 1

617-006-00-X

Bis(α,α-dimethylbenzyl)peroxid

201-279-3

80-43-3

Org. Perox. F

Repr. 1B

Skin Irrit. 2

Eye Irrit. 2

Aquatic Chronic 2

H242

H360D

H315

H319

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H242

H360D

H315

H319

H411

648-055-00-5

Pech, Kohlenteer, Hochtemperatur; [Rückstand aus der Destillation von Hochtemperatur-Kohlenteer. Schwarzer Feststoff mit einem Erweichungspunkt von etwa 30 °C bis 180 °C (86 °F bis 356 °F). Besteht in erster Linie aus einem komplexen Gemisch von aromatischen Kohlenwasserstoffen mit drei- oder mehrgliedrigen Ringsystemen.]

266-028-2

65996-93-2

Carc. 1A

Muta. 1B

Repr. 1B

H350

H340

H360FD

GHS08

Dgr

H350

H340

H360FD

650-056-00-0

Dibutylbis(pentan-2,4-dionato-O,O’)tin

245-152-0

22673-19-4

Repr. 1B

STOT RE 1

H360FD

H372 (Immunsystem)

GHS08

Dgr

H360FD

H372 (Immunsystem)

650-057-00-6

Margosa, Extrakt [kaltgepresstes Öl aus den geschälten Kernen von Azadirachta indica, mit überkritischem Kohlendioxid extrahiert]

283-644-7

84696-25-3

Aquatic Chronic 3

H412

H412